Business Context and Reporting Period
This Form 8-K is filed by BioSig Technologies, Inc. (not Streamex Corp.) on May 6, 2024. The report addresses the status of the Company's listing on The Nasdaq Capital Market under Item 3.01 regarding delisting notices and compliance with listing standards.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric referenced is the minimum bid price of $1.00 per share required for continued listing.
Material Changes Versus Prior Period
- Bid Price Compliance: The Company has regained compliance with Nasdaq Listing Rule 5550(a)(2). The common stock closed at or above $1.00 per share for 20 consecutive business days from April 8, 2024, to May 3, 2024.
- Delisting Status: While the bid price issue is resolved, the Company remains non-compliant with other requirements, including market value of listed securities, public shell status, and independent board/committee requirements.
Outlook, Risks, and Management Commentary
- Upcoming Hearing: A hearing before the Nasdaq Hearings Panel is scheduled for May 7, 2024, to address the remaining non-compliance issues.
- Risk of Delisting: Despite regaining bid price compliance, the Company faces continued risk of delisting due to failures to meet equity, market value, and governance standards.
- Management Action: The Company previously appealed the delisting determination on March 11, 2024, and continues to engage with the Nasdaq Staff.
Investor Verification Checklist
- Verify the outcome of the Nasdaq Hearings Panel scheduled for May 7, 2024.
- Confirm the Company's progress on meeting the $5,000,000 minimum stockholders' equity requirement.
- Monitor the stock price to ensure it remains above the $1.00 threshold to maintain bid price compliance.
- Review the Company's status regarding public shell and independent board requirements.